Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study on Efficacy and Tolerance of Intravitreous Injection of Ranibizumab (Lucentis®) in Early-onset Central Retinal Vein Occlusion in Comparison to Hemodilution Using Erythrocytapheresis

NCT01448018 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal Creteil as lead sponsor.

NCT NCT01448018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01448018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study on Efficacy and Tolerance of Intravitreous Injection of Ranibizumab (Lucentis®) in Early-onset Central Retinal Vein Occlusion in Comparison to Hemodilution Using Erythrocytapheresis
Lead sponsor
Centre Hospitalier Intercommunal Creteil
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2013
Enrollment
45 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal vein occlusion